ABVC BioPharma, Inc. (ABVC) Q1 2026 Earnings

Screener

Reported May 18, 2026 · After market close

EPS-$0.06

Next report

Nov 16, 2026 (in 3 months)

Revenue estimate$113.3K

EPS estimate-$0.40

Versus estimates

Revenue

Q4 2025-$796.0K Q3 2025$796.0K

Diluted EPS

Q2 2026-$0.03Beat by $0.37

Q1 2026-$0.06

Q4 2025-$0.12 Q3 2025-$0.05 Q2 2025-$0.13 Q1 2025-$0.06

FAQ

When did ABVC BioPharma, Inc. report Q1 2026 earnings?: ABVC BioPharma, Inc. (ABVC) reported Q1 2026 earnings on May 18, 2026 after market close.
What were ABVC BioPharma, Inc.'s Q1 2026 revenue and EPS?: ABVC BioPharma, Inc. reported eps of $-0.06 for Q1 2026.
How did ABVC BioPharma, Inc.'s Q1 2026 results compare year-over-year?: Compared to the same quarter a year prior, eps grew 0.0% from $-0.06.
Where can I find ABVC BioPharma, Inc.'s Q1 2026 SEC filings?: You can read the 10-Q periodic report (0001213900-26-058104) directly on SEC EDGAR. The filing index links above go to sec.gov.

Ask the moment ABVC BioPharma, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk